|
?:authorAffiliation
|
-
[\'Laboratory of Emerging Pathogens, Fondation Mérieux, Lyon, France.\', \'Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.\', \'Médecins Sans Frontières, Geneva, Switzerland.\', \'Department Biology, Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA, USA.\', \'Francis I Proctor Foundation, University of California San Francisco, CA, USA.\', \'Epicentre, Yaounde, Cameroon.\', \'Epicentre, Paris, France.\', \'Departments of Epidemiology and of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA USA.\', \'School of Medicine, University of California San Francisco, CA, USA.\', \'WHO Collaborating Center for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.\', \'IRESSEF (Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formation), Dakar, Senegal.\', \'Institut Pasteur de Bangui, Bangui, Central African Republic.\', \'Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, UT, USA daniel.leung@utah.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}